Author Login IJIRT Partner Network (IPN) Login

An Overview of the New Drug Submission and Approval Process for Canada

  • Unique Paper ID: 161005
  • Volume: 10
  • Issue: 2
  • PageNo: 310-315
  • Abstract:
  • Health Canada is a 9th largest growing pharmaceutical market in the world. The Health Canada is the regulatory Authority of Canada that works under department of Minister of Health. Health Canada is responsible to approve the New Pharmaceutical Drug in Canada under the Food and Drug Branch with applicable Food and Drug Act and its Regulations. The health Canada is also responsible for approval or rejection of the various types of applications related to drug in Canada. There are Various submission types are there in Health Canada i.e., NDA, SNDA, ANDA, SANDA. In the present review article, we will discuss about the New Drug Submission and approval process in Canada.
Download article email to a friend

Cite This Article

  • ISSN: 2349-6002
  • Volume: 10
  • Issue: 2
  • PageNo: 310-315

An Overview of the New Drug Submission and Approval Process for Canada

Related Articles

Impact Factor
8.01 (Year 2024)
UGC Approved
Journal no 47859

Join Our IPN

IJIRT Partner Network

Submit your research paper and those of your network (friends, colleagues, or peers) through your IPN account, and receive 800 INR for each paper that gets published.

Join Now

Latest Publication

Archive

View More

Recent Conferences

NCSEM 2024

National Conference on Sustainable Engineering and Management - 2024 Last Date: 15th March 2024

Submit inquiry